David A. Wheeler
Expertise in
33
conditions

Dr. David A. Wheeler

Infectious Disease | Internal Medicine
3289 Woodburn Rd, 200, 
Annandale, VA 
Offers Telehealth
44 Years of Experience
Expertise in
33
conditions
3289 Woodburn Rd, 200, 
Annandale, VA 

Overview

David Wheeler is an Infectious Disease specialist and an Internal Medicine provider practicing medicine in Annandale, Virginia. He has been practicing medicine for over 44 years.

Dr. Wheeler is highly rated in 33 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

He is actively involved in clinical research, co-authoring 144 peer reviewed articles and participating in 4 clinical trials.

Graduate Institution

University Of Virginia School Of Medicine, 1982

Residency

University of Colorado School of Medicine Training Specialty: Internal Medicine 7/1/1983 - 6/30/1985

Specialties

Infectious Disease
Internal Medicine

Licenses

Internal Medicine in VA

Fellowships

University of Maryland Medical System Training Specialty: Infectious Disease 7/1/1989 - 6/30/1991

Hospital Affiliations

Inova Alexandria Hospital
Inova Fairfax Hospital

Languages Spoken

English
Portuguese
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Innovation Health
  • HMO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Infectious Diseases Physicians Inc
3289 Woodburn Rd, 200, Annandale, VA 22003

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase IIb, Multicenter, Open-label, Rollover Study Evaluating the Efficacy, Safety and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months in HIV-1 Infected Adults Who Are Virologically Suppressed and Participated in Study LAI116482
A Phase IIb, Multicenter, Open-label, Rollover Study Evaluating the Efficacy, Safety and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months in HIV-1 Infected Adults Who Are Virologically Suppressed and Participated in Study LAI116482
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drugs: Long-acting cabotegravir, Long-acting rilpivirine, Rilpivirine, Dolutegravir
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
Dalbavancin For The Treatment Of Gram Positive Osteomyelitis Or Joint Infections Including Prosthetic Hip Or Knee Infections
Dalbavancin For The Treatment Of Gram Positive Osteomyelitis Or Joint Infections Including Prosthetic Hip Or Knee Infections
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Drug
Study Drugs: Dalbavancin, Vancomycin
Study Phase: Phase 4
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
View 3 Less Clinical Trials

144 Total Publications

NOTCH1 acts as a tumor suppressor that induces early differentiation in head and neck cancer.
NOTCH1 acts as a tumor suppressor that induces early differentiation in head and neck cancer.
Journal: JCI insight
Published: November 20, 2025
Similar Doctors
Expertise in
1
conditions
Dr. Naomi Aronson
Infectious Disease
Expertise in
1
conditions
Dr. Naomi Aronson
Infectious Disease
Referral may be required

Office

6900 Georgia Ave, 
Washington, DC 
 (19.8 miles away)
202-782-1663
Languages Spoken:
English

Naomi Aronson is an Infectious Disease provider practicing medicine in Washington, Washington, D.c.. Dr. Aronson is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Leishmaniasis.

Expertise in
7
conditions
Dr. Amy Klion
Infectious Disease
Expertise in
7
conditions
Dr. Amy Klion
Infectious Disease
Referral may be required

Office

9000 Rockville Pike, 
Bethesda, MD 
 (15.6 miles away)
301-435-8903
Languages Spoken:
English

Amy Klion is an Infectious Disease provider practicing medicine in Bethesda, Maryland. Dr. Klion is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Loiasis, Spirurida Infections, Secernentea Infections, Helminthiasis, and Tissue Biopsy.

Expertise in
2
conditions
Dr. Christian Ockenhouse
Infectious Disease
Expertise in
2
conditions
Dr. Christian Ockenhouse
Infectious Disease
Referral may be required

Office

6900 Georgia Ave, 
Washington, DC 
 (19.8 miles away)
301-319-9473
Languages Spoken:
English

Christian Ockenhouse is an Infectious Disease provider practicing medicine in Washington, Washington, D.c.. Dr. Ockenhouse is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Malaria and Sepsis.

Frequently Asked Questions about Dr. David A. Wheeler

How do I make an appointment with Dr. David A. Wheeler?

You can book an appointment with Dr. David A. Wheeler by calling their office at 703-560-7900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David A. Wheeler a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David A. Wheeler is classified as an Distinguished expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David A. Wheeler specialize in?

While Dr. David A. Wheeler is a Infectious Disease, they have specific expertise in HIV/AIDS, Myelitis, and AIDS Dysmorphic Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. David A. Wheeler participate in research or clinical trials?

Yes. Dr. David A. Wheeler has published 144 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. David A. Wheeler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David A. Wheeler accept my insurance?

Dr. David A. Wheeler accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 703-560-7900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wheeler's expertise for a condition
ConditionClose
    View All 29 Advanced Conditions
    View All 65 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile